Canlyniadau Chwilio - David Capper

Mireinio'r Canlyniadau
  1. 1
    <scp>WHO</scp> 2016 Classification of gliomas

    <scp>WHO</scp> 2016 Classification of gliomas gan Pieter Wesseling, David Capper

    Cyhoeddwyd 2017
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Invited Review: DNA methylation‐based classification of paediatric brain tumours

    Invited Review: DNA methylation‐based classification of paediatric brain tumours gan Eilís Pérez, David Capper

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach

    Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach gan David Capper, Michel Mittelbronn, Richard Meyermann, Jens Schittenhelm

    Cyhoeddwyd 2007
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT

    Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT gan Matthias S. Dettmer, Anja Schmitt, Hans C. Steinert, David Capper, Holger Moch, Paul Komminoth, Aurel Perren

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E

    Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E gan Ildikó Mesteri, Günther Bayer, Jochen Meyer, David Capper, Sebastian F. Schoppmann, Andreas von Deimling, Peter Birner

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    PCR‐ and Restriction Endonuclease‐Based Detection of <i>IDH1</i> Mutations

    PCR‐ and Restriction Endonuclease‐Based Detection of <i>IDH1</i> Mutations gan Jochen Meyer, Stefan Pusch, Jörg Balß, David Capper, Wolf Mueller, Arne Christians, Christian Hartmann, Andreas von Deimling

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics

    Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics gan Salvatore Benfatto, Martin Sill, David Jones, Stefan M. Pfister, Felix Sahm, Andreas von Deimling, David Capper, Volker Hovestadt

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Detection of 2‐Hydroxyglutarate in Formalin‐Fixed Paraffin‐Embedded Glioma Specimens by Gas Chromatography/Mass Spectrometry

    Detection of 2‐Hydroxyglutarate in Formalin‐Fixed Paraffin‐Embedded Glioma Specimens by Gas Chromatography/Mass Spectrometry gan Felix Sahm, David Capper, Stefan Pusch, Jörg Balß, Arend Koch, Claus‐Dieter Langhans, Jürgen G. Okun, Andreas von Deimling

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Management of pineal region tumors in a pediatric case series

    Management of pineal region tumors in a pediatric case series gan Matthias Schulz, Melissa Afshar-Bakshloo, Arend Koch, David Capper, Pablo Hernáiz Driever, Anna Tietze, Arne Grün, Ulrich‐Wilhelm Thomale

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Machine learning models predict the primary sites of head and neck squamous cell carcinoma metastases based on <scp>DNA</scp> methylation

    Machine learning models predict the primary sites of head and neck squamous cell carcinoma metastases based on <scp>DNA</scp> methylation gan Maximilian Leitheiser, David Capper, Philipp Seegerer, Annika Lehmann, Ulrich Schüller, Klaus‐Robert Müller, Frederick Klauschen, Philipp Jurmeister, Michael Bockmayr

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    BRAF V600E‐specific immunohistochemistry for the exclusion of Lynch syndrome in MSI‐H colorectal cancer

    BRAF V600E‐specific immunohistochemistry for the exclusion of Lynch syndrome in MSI‐H colorectal cancer gan David Capper, Anita Y. Voigt, Gergana Bozukova, Aysel Ahadova, Philipp Kickingereder, Andreas von Deimling, Magnus von Knebel Doeberitz, Matthias Kloor

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    2‐Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size

    2‐Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size gan David Capper, Matthias Simon, Claus‐Dieter Langhans, Jürgen G. Okun, Jörg C. Tonn, Michael Weller, Andreas von Deimling, Christian Hartmann

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolution

    A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolution gan Tianyu Zhu, Jacklyn Liu, Stephan Beck, Pan Sun, David Capper, Matt Lechner, Chrissie Thirlwell, Charles E. Breeze, Andrew E. Teschendorff

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients

    Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients gan Christine Jungk, Despina Chatziaslanidou, Rezvan Ahmadi, David Capper, Justo Lorenzo Bermejo, Janina Exner, Andreas von Deimling, Christel Herold‐Mende, Andreas Unterberg

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre

    Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre gan Zane Jaunmuktane, David Capper, David Jones, Daniel Schrimpf, Martin Sill, Monika Dutt, Nirosha Suraweera, Stefan M. Pfister, Andreas von Deimling, Sebastian Brandner

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entity

    High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entity gan Katja Bender, Eilís Pérez, Mihaela Chirica, Julia Onken, Johannes Kahn, Winfried Brenner, Felix Ehret, Philipp Euskirchen, Arend Koch, David Capper, David Kaul

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Conumee 2.0: enhanced copy-number variation analysis from DNA methylation arrays for humans and mice

    Conumee 2.0: enhanced copy-number variation analysis from DNA methylation arrays for humans and mice gan Bjarne Daenekas, Eilís Pérez, Fabio Boniolo, Sabina Ştefan, Salvatore Benfatto, Martin Sill, Dominik Sturm, David Jones, David Capper, Marc Zapatka, Volker Hovestadt

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Real-world experience with TTFields in glioma patients with emphasis on therapy usage

    Real-world experience with TTFields in glioma patients with emphasis on therapy usage gan Claudius Jelgersma, Joan Alsolivany, Gülsüm Akkas, David Wasilewski, Bastian Gastl, Martin Misch, David Capper, David Kaul, Lars Bullinger, Peter Vajkoczy, Julia Onken

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Characterization of R132H Mutation‐specific IDH1 Antibody Binding in Brain Tumors

    Characterization of R132H Mutation‐specific IDH1 Antibody Binding in Brain Tumors gan David Capper, Susanne Weißert, Jörg Balß, Antje Habel, Jochen Meyer, Diana Jäger, Ulrike Ackermann, Claudia Tessmer, Andrey Korshunov, Hanswalter Zentgraf, Christian Hartmann, Andreas von Deimling

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors

    The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors gan Alon D. Altman, Gregg Nelson, Prafull Ghatage, John B. McIntyre, David Capper, Pamela Chu, Jill Nation, Anthony N. Karnezis, Guangming Han, Steve E. Kalloger, Martin Köbel

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: